Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $637,917. The enterprise value is -$3.65 million.
| Market Cap | 637,917 |
| Enterprise Value | -3.65M |
Important Dates
The last earnings date was Friday, September 11, 2026, after market close.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BDRX has 1.03 million shares outstanding. The number of shares has increased by 1,335.06% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.03M |
| Shares Change (YoY) | +1,335.06% |
| Shares Change (QoQ) | +341.93% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 0.17% |
| Float | 943,491 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.04 |
| P/TBV Ratio | 0.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41
| Current Ratio | 2.41 |
| Quick Ratio | 2.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -58.15 |
Financial Efficiency
Return on equity (ROE) is -42.00% and return on invested capital (ROIC) is -138.48%.
| Return on Equity (ROE) | -42.00% |
| Return on Assets (ROA) | -40.11% |
| Return on Invested Capital (ROIC) | -138.48% |
| Return on Capital Employed (ROCE) | -88.89% |
| Weighted Average Cost of Capital (WACC) | 11.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$533,127 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BDRX has paid $137,986 in taxes.
| Income Tax | 137,986 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.12% in the last 52 weeks. The beta is 1.29, so BDRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -98.12% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 4.62 |
| Relative Strength Index (RSI) | 36.28 |
| Average Volume (20 Days) | 10,614,084 |
Short Selling Information
The latest short interest is 271,866, so 26.42% of the outstanding shares have been sold short.
| Short Interest | 271,866 |
| Short Previous Month | 33,356 |
| Short % of Shares Out | 26.42% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | -6.92M |
| Operating Income | -11.73M |
| Pretax Income | -5.73M |
| Net Income | -5.86M |
| EBITDA | -11.74M |
| EBIT | -11.73M |
| Earnings Per Share (EPS) | -$12.81 |
Balance Sheet
The company has $4.29 million in cash and no debt, with a net cash position of $4.29 million or $4.16 per share.
| Cash & Cash Equivalents | 4.29M |
| Total Debt | n/a |
| Net Cash | 4.29M |
| Net Cash Per Share | $4.16 |
| Equity (Book Value) | 12.75M |
| Book Value Per Share | 17.09 |
| Working Capital | 5.19M |
Cash Flow
In the last 12 months, operating cash flow was -$9.13 million and capital expenditures -$9,267, giving a free cash flow of -$9.14 million.
| Operating Cash Flow | -9.13M |
| Capital Expenditures | -9,267 |
| Depreciation & Amortization | -10,591 |
| Net Borrowing | -697,695 |
| Free Cash Flow | -9.14M |
| FCF Per Share | -$8.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,335.06% |
| Shareholder Yield | -1,335.06% |
| Earnings Yield | -919.30% |
| FCF Yield | -1,433.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 6, 2026. It was a reverse split with a ratio of 1:5.
| Last Split Date | Apr 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |